These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33550108)

  • 1. DNT1 Downregulation and Increased Ethanol Sensitivity in Transgenic Drosophila Models of Alzheimer's Disease.
    Nikookar H; Haddadi M; Haghi M; Masoudi R
    Arch Gerontol Geriatr; 2021; 94():104355. PubMed ID: 33550108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinctive alteration in the expression of autophagy genes in Drosophila models of amyloidopathy and tauopathy.
    Haghi M; Masoudi R; Najibi SM
    Ups J Med Sci; 2020 Nov; 125(4):265-273. PubMed ID: 32657227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pro-domains of neurotrophins, including BDNF, are linked to Alzheimer's disease through a toxic synergy with Aβ.
    Lim JY; Reighard CP; Crowther DC
    Hum Mol Genet; 2015 Jul; 24(14):3929-38. PubMed ID: 25954034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau downregulates BDNF expression in animal and cellular models of Alzheimer's disease.
    Rosa E; Mahendram S; Ke YD; Ittner LM; Ginsberg SD; Fahnestock M
    Neurobiol Aging; 2016 Dec; 48():135-142. PubMed ID: 27676333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential dysregulation of CREB and synaptic genes in transgenic Drosophila melanogaster expressing shaggy (GSK3), Tau
    Ataellahi F; Masoudi R; Haddadi M
    Mol Biol Rep; 2023 Feb; 50(2):1101-1108. PubMed ID: 36399243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The distinctive role of tau and amyloid beta in mitochondrial dysfunction through alteration in Mfn2 and Drp1 mRNA Levels: A comparative study in Drosophila melanogaster.
    Abtahi SL; Masoudi R; Haddadi M
    Gene; 2020 Sep; 754():144854. PubMed ID: 32525045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abeta exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease.
    Folwell J; Cowan CM; Ubhi KK; Shiabh H; Newman TA; Shepherd D; Mudher A
    Exp Neurol; 2010 Jun; 223(2):401-9. PubMed ID: 19782075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
    Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
    J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active full-length DNA Aβ
    Rosenberg RN; Fu M; Lambracht-Washington D
    Alzheimers Res Ther; 2018 Nov; 10(1):115. PubMed ID: 30454039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport.
    Sherman MA; LaCroix M; Amar F; Larson ME; Forster C; Aguzzi A; Bennett DA; Ramsden M; Lesné SE
    J Neurosci; 2016 Sep; 36(37):9647-58. PubMed ID: 27629715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
    Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
    Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tau on Aβ-induced synaptic damage in a Drosophila model of Alzheimer's disease.
    Wang Q; Ying L; Huang F; Lin J; Wang W
    Neuro Endocrinol Lett; 2022 Jun; 43(2):68-76. PubMed ID: 35786817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
    Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
    Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
    Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of Immunomagnetic Reduction Technology as a Biosensor in Therapeutic Evaluation of Chinese Herbal Medicine in Tauopathy Alleviation of an AD
    Su MT; Lu CW; Wu WJ; Jheng YS; Yang SY; Chuang WC; Lee MC; Wu CH
    Biosensors (Basel); 2022 Oct; 12(10):. PubMed ID: 36291020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.
    Imamura T; Yanagihara YT; Ohyagi Y; Nakamura N; Iinuma KM; Yamasaki R; Asai H; Maeda M; Murakami K; Irie K; Kira JI
    Neurobiol Dis; 2020 Apr; 137():104739. PubMed ID: 31927145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stabilization of Microtubule-Unbound Tau via Tau Phosphorylation at Ser262/356 by Par-1/MARK Contributes to Augmentation of AD-Related Phosphorylation and Aβ42-Induced Tau Toxicity.
    Ando K; Maruko-Otake A; Ohtake Y; Hayashishita M; Sekiya M; Iijima KM
    PLoS Genet; 2016 Mar; 12(3):e1005917. PubMed ID: 27023670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Downregulation of
    Park SY; Seo J; Chun YS
    J Korean Med Sci; 2019 Aug; 34(33):e225. PubMed ID: 31436053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.